Healthy

Showing NaN - NaN of 252

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Seoul (DA-5215 Tab, DA-5215-R Tab)

Not yet recruiting
  • Healthy
  • DA-5215 Tab
  • DA-5215-R Tab
  • Seoul, Korea, Republic of
    H Plus Yangji Hospital
May 11, 2022

Healthy Trial in Seoul (IN-C005 X mg, IN-A001 Y mg, IN-C005 Y mg)

Completed
  • Healthy
  • IN-C005 X mg
  • +3 more
  • Seoul, Jongro Gu, Korea, Republic of
  • +1 more
May 10, 2022

Healthy Trial in Seoul (Tacrolimus, IN-A001(Tegoprazan), IN-A001(Tegoprazan) + Tacrolimus)

Not yet recruiting
  • Healthy
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 25, 2022

Healthy Trial in Seoul (CG-745 IV Solution, CG-750 125mg capsule, PO Placebo)

Completed
  • Healthy
  • CG-745 IV Solution
  • +3 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 19, 2022

Healthy Trial in Seoul (SJP002, Placebo)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 7, 2022

Healthy Trial in Seoul (SA001 60mg or Placebo, SA001 120mg or Placebo, SA001 180mg or Placebo)

Completed
  • Healthy
  • SA001 60mg or Placebo
  • +4 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 20, 2022

Colorectal Cancer, Colon Polyp, Healthy Trial in Korea, Republic of (Earlytect Colon Cancer)

Active, not recruiting
  • Colorectal Cancer
  • +2 more
  • Earlytect Colon Cancer
  • Busan, Korea, Republic of
  • +7 more
Feb 27, 2022

Healthy Trial in Seoul (probucol)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Seoul national univeristy
Feb 17, 2022

Healthy Trial in Seoul (Cilostazol, Probucol)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Clinical Trial Center, Seoul National University Hospital
Feb 17, 2022

Healthy Trial in Seoul (CTO0101, Placebo (vehicle))

Recruiting
  • Healthy
  • Seoul, Korea, Republic of
    Taejoon Pharmaceutical Co., Ltd.
Feb 21, 2022

Healthy Trial in Seoul (YH4808 NF 100, YH4808 OF 200, YH4808 NF 200)

Completed
  • Healthy
  • YH4808 NF 100
  • +3 more
  • Seoul, Korea, Republic of
    Yonsei Medical Center Severance Hospital Clinical Trials Center
Dec 26, 2021

Healthy Trial in Seoul (HCP1904-1, RLD2006, RLD2001-2)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Yangji Hospital
Jan 2, 2022

Healthy Trial in Korea, Republic of (CT-P17, US-licensed Humira, EU-approved Humira)

Completed
  • Healthy
  • CT-P17
  • +2 more
  • Cheongju-si, Chungcheongbuk-do, Korea, Republic of
  • +8 more
Nov 17, 2021

Healthy Trial in Seoul (NXC736, Placebo)

Recruiting
  • Healthy
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 12, 2021

Healthy Trial in Seoul (IN-A002(IN-115314) capsule)

Recruiting
  • Healthy
  • IN-A002(IN-115314) capsule
  • Seoul, Korea, Republic of
    Seoul National University Hospital, Dept. of Clinical Pharmacolo
Aug 19, 2021

Healthy Trial in Seoul (Normal saline, DWJ1521, DWP14012 Tablet)

Recruiting
  • Healthy
  • Normal saline
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jun 8, 2021

Healthy Trial in Seoul (IN-A012, Akynzeo 300Mg-0.5Mg Capsule)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Catholic Univ. of Seoul St. Mary's Hospital
May 28, 2021

Healthy Trial in Seoul (hzVSF-v13, Placebo)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 4, 2021

Healthy Trial in Seoul (Aricept 5mg Tablet, Aricept 10mg Tablet, DA-5207 150mg)

Active, not recruiting
  • Healthy
  • Aricept 5mg Tablet
  • +3 more
  • Seoul, Korea, Republic of
    Severance Hospital Clinical Trial Center
Apr 13, 2021

Healthy Trial in Seoul (DA-5207, Donepezil Hydrochloride)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Clinical Trials Center, Severance Hospital
Apr 13, 2021

Healthy Trial in Seoul (LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose)

Completed
  • Healthy
  • LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 10, 2021

Healthy Trial in Seoul (NVP-1805, NVP-1805-R1and NVP-1805-R2)

Completed
  • Healthy
  • Seoul, Nambusunhwan-ro, Korea, Republic of
    H Plus Yangji Hospital
Mar 1, 2021

Healthy Trial in Seoul (DA-5209 60mg Tab, Lixiana 60mg Tab)

Completed
  • Healthy
  • DA-5209 60mg Tab
  • Lixiana 60mg Tab
  • Seoul, Korea, Republic of
    H Plus Yangji Hospital
Feb 8, 2021

Healthy Trial in Seoul (Eletriptan commercial tablet)

Completed
  • Healthy
  • Eletriptan commercial tablet
  • Seoul, Korea, Republic of
    Pfizer Investigational Site
Jan 26, 2021

Healthy Trial in Seoul (Tegoprazan 50 mg, EAPA115, RAPA115)

Completed
  • Healthy
  • Tegoprazan 50 mg
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital, Clinical Trial Center
Nov 29, 2020